Butyric acid supplementation presents exciting possibilities for treating ASD symptoms by supporting the gut microbiome and addressing gastrointestinal disturbances.
As the dangers of oxidative stress become increasingly evident, there is reason to believe that lowering this stress via glutathione supplementation could help patients optimize well-being.
Though GABA’s impact in the body is well-understood, far less is known about the efficacy or side effects of GABA supplements, and patients may wish to investigate alternative supplementation for greater therapeutic potential and known safety.
Early studies suggest that glutathione may aid in the prevention and/or management of a wide variety of serious conditions, ranging from neurological diseases and gastrointestinal conditions to aging skin.
Many patients with autism use probiotics due to their purported benefits for both gastrointestinal and behavioral symptoms, but it’s important to understand any potential side effects and consider whether there may be superior alternatives.
While IV administration of glutathione has few side effects, it may not be the optimal treatment solution when it comes to the patient’s lifestyle concerns, like those with Parkinson’s disease and autism spectrum disorder,
Today, researchers understand oxidative stress as one of the key cellular processes involved in autism, spurring interest in finding all-natural nutritional supplements that reduce oxidative stress to improve outcomes for patients.
The benefits of curcumin stem primarily from its anti-inflammatory and antioxidant activities, but it also has antimicrobial and protein regulatory properties that further expand its potential benefits as a therapy.
Caregivers who are looking for a new therapy to reduce agitated or anxious behavior in patients with ASD must be careful when evaluating GABA as a treatment option and may want to explore alternative therapies.
The appeal of antioxidants hinges in part on the notion that they are less likely to have side effects than standard pharmaceutical treatments, but this idea has been called into question over the years.
Today, dietary supplement use is increasingly prevalent among patients with autism, but caregivers seeking to take advantage these therapies need to consider their options carefully to find an effective and safe solution.
In light of growing evidence, researchers are now considering the endocannabinoid system as a possible target for future therapeutics that treat social anxiety in patients with autism.